Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine

被引：0
作者：
O. Juan
J. Vidal
R. Gisbert
J. Muñoz
S. Maciá
J. Gómez-Codina
机构：
[1] Hospital Universitari I Politècnic La Fe,Medical Oncology Department
[2] Hospital Arnau de Vilanova,Clinical Laboratory
[3] Hospital Dr Peset,Medical Oncology Department
[4] Hospital General de Elda,Medical Oncology Department
来源：
Clinical and Translational Oncology | 2014年 / 16卷
关键词：
Lung cancer; Circulating tumor cells; Prognosis; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：637 / 643
页数：6
相关论文
共 50 条
  • [21] Prognostic value of tumor mutations in radically treated locally advanced non-small cell lung cancer patients
    Boros, Angela
    Lacroix, Ludovic
    Lacas, Benjamin
    Adam, Julien
    Pignon, Jean-Pierre
    Caramella, Caroline
    Planchard, David
    de Montpreville, Vincent
    Deutsch, Eric
    Levy, Antonin
    Besse, Benjamin
    Le Pechoux, Cecile
    ONCOTARGET, 2017, 8 (15) : 25189 - 25199
  • [22] Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
    Naito, Tateaki
    Tanaka, Fumihiro
    Ono, Akira
    Yoneda, Kazue
    Takahashi, Toshiaki
    Murakami, Haruyasu
    Nakamura, Yukiko
    Tsuya, Asuka
    Kenmotsu, Hirotsugu
    Shukuya, Takehito
    Kaira, Kyoichi
    Koh, Yasuhiro
    Endo, Masahiro
    Hasegawa, Seiki
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (03) : 512 - 519
  • [23] Prognostic significance of RASSF1A promoter methylation on survival of non-small cell lung cancer patients treated with gemcitabine
    Fischer, Juergen R.
    Ohnmacht, Ute
    Rieger, Norman
    Zemaitis, Marius
    Stoffregen, Clemens
    Manegold, Christian
    Lahm, Harald
    LUNG CANCER, 2007, 56 (01) : 115 - 123
  • [24] Clinical Significance of Circulating Tumor Cells and Free DNA in Non-small Cell Lung Cancer
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Kobayashi, Kunihiko
    Hirota, Nao
    Sato, Keita
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Shibuya, Kazutoshi
    Takagi, Keigo
    Homma, Sakae
    ANTICANCER RESEARCH, 2012, 32 (08) : 3339 - 3344
  • [25] Prognostic significance of RelB overexpression in non-small cell lung cancer patients
    Qin, Hualong
    Zhou, Jun
    Zhou, Peng
    Xu, Jingjing
    Tang, Zaixiang
    Ma, Haitao
    Guo, Feng
    THORACIC CANCER, 2016, 7 (04) : 415 - 421
  • [26] A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer
    Petty, W. Jeffrey
    Knight, Sommer N.
    Mosley, Libyadda
    Lovato, James
    Capellari, James
    Tucker, Robert
    Blackstock, A. William
    Miller, Mark Steven
    Miller, Antomus A.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (03) : 197 - 202
  • [27] Influence of altering administration sequence of docetaxel, gemcitabine and cisplatin in patients with advanced non-small cell lung cancer
    Harita, S
    Watanabe, Y
    Kiura, K
    Tabata, M
    Takigawa, N
    Kuyama, S
    Kozuki, T
    Kamei, H
    Tada, A
    Okimoto, N
    Genba, K
    Tada, S
    Ueoka, H
    Hiraki, S
    Tanimoto, M
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1637 - 1641
  • [28] Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer
    Sirera, Rafael
    Bremnes, Roy M.
    Cabrera, Andrea
    Jantus-Lewintre, Eloisa
    Sanmartin, Elena
    Blasco, Ana
    del Pozo, Nieves
    Rosell, Rafael
    Guijarro, Ricardo
    Galbis, Jose
    Javier Sanchez, Jose
    Camps, Carlos
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (02) : 286 - 290
  • [29] Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy
    Pallis, A. G.
    Agelaki, S.
    Kakolyris, S.
    Kotsakis, A.
    Kalykaki, A.
    Vardakis, N.
    Papakotoulas, P.
    Agelidou, A.
    Geroyianni, A.
    Agelidou, M.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    LUNG CANCER, 2008, 62 (03) : 356 - 363
  • [30] Feasibility Study of Nivolumab and Docetaxel in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
    Shimokawa, T.
    Nakamura, Y.
    Iwasawa, S.
    Miyazaki, K.
    Yamanaka, T.
    Takiguchi, Y.
    Okamoto, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2431 - S2431
12345